- Will ‘Game-Changer’ Antipsychotic Live Up to the Hype? Medscape
- Schizophrenia: the new drug set to tackle the ‘cancer of psychiatry’ Financial Times
- Schizophrenia Space Anticipates First-in-Class FDA Approval for BMS’ KarXT BioSpace
- Bristol-Myers Acquired Drug KarXT Poised For FDA Approval…
[ad_2]
Source link